Institutional investors purchased a net $22.5 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 37.63% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE ASSET MANAGEMENT (... Bought 2.7 Million shares of Moderna Inc
NORTHERN TRUST GLOBAL INVESTMENT... Bought 79.0 Thousand shares of Moderna Inc
CREDIT SUISSE AG Bought 47.1 Thousand shares of Moderna Inc